Company Revenue

The company declined in the high teens for 2Q22 as it works to establish new baselines for its sales geographies...

The company declined in the low-single digits in 2Q22 as hospital staffing pressures impacted case volumes for complex spine procedures....

The company grew over +20% in 2Q22, bolstered by revenue contributions from recently acquired Pega Medical and MD Orthopedics....

The company's product revenue declined in the low-single digits for 2Q22 while supply chain disruption impacted three new products....

The company grew more than 35% in 2Q22, driven by accelerating adoption of the ATEC's PTP procedure and growing EOS...

The company grew in the mid-single digits against a difficult comparison, notching its highest revenue quarter and June ever....

The company grew in the mid-single digits for 2Q22, driven by favorable order timing for its joint pain management business....

The company's orthopedic revenue grew nearly 40% in the second quarter of 2022 on the strength of recent acquisitions like...

Company sales grew almost 19% in 2Q22 as Paragon 28 closed portfolio gaps, expanded its sales force and grew its...

The company grew in the high teens for 2Q22 as its expanding portfolio and 7D unit placements drove market share...